Clinical Trial Update: Efficacy of Probiotic Lactobacillus Crispatus M247 in Promoting High-risk Human Papillomavirus (HR-HPV) Infection Clearance and Modifying Vaginal Microbiota [NA]

View source ↗

Summary

A completed clinical trial evaluating the probiotic Lactobacillus crispatus M247 for promoting clearance of high-risk human papillomavirus (HR-HPV) infection an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• Lactobacillus crispatus M247

Snippet

Sponsor: Liaquat University of Medical & Health Sciences | Conditions: Human Papillomavirus Infection | NA | Status: COMPLETED